TrialScientific reports2025

Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial.

Zeinab Sadat Hosseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.